Biomarker Discovery for Early Detection of Pancreatic Ductal Adenocarcinoma
Biomarker Discovery for Early Detection of Pancreatic Ductal Adenocarcinoma
批准号:
7962113
负责人:
CHRISTOPHER KLUG
金额:
$60.53万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-03-01 至 2015-02-28
关键词:
AccountingAllelesAnimal ModelAntibodiesArtsBiological AssayBiological MarkersBiotinylationBlindedCachexiaCancer DetectionCancer EtiologyCancer PatientCarcinomaCell LineCell surfaceCessation of lifeDevelopmentDiabetes MellitusDiagnosisDiagnosticDiseaseDuctal Epithelial CellDuctal EpitheliumEarly DiagnosisExcisionFunctional disorderGelGeneticGenetically Engineered MouseGoalsHistologyHumanInbred MouseInflammationInstructionKRAS2 geneLesionMALDI-TOF Mass SpectrometryMalignant NeoplasmsMalignant neoplasm of pancreasMass Spectrum AnalysisModelingMusMutationNatureNeoplasm MetastasisNeoplasmsOperative Surgical ProceduresOrganPancreasPancreatic DiseasesPancreatic Ductal AdenocarcinomaPatientsProteomeProteomicsRadiation therapyResistanceSamplingSensitivity and SpecificitySerumSourceStagingSurvival RateSystemTechnologyTestingTissuesUnited StatesWorkadvanced diseasebasechemotherapychronic pancreatitishigh riskmortalitymouse modelneoplasticoutcome forecastpancreatic neoplasmprospectiveresearch studytumortwo-dimensional
中文摘要
项目概述(见说明):
英文摘要
PROJECT SUMMARY (See instructions):
Infiltrating pancreatic ductal adenocarcinoma (PDAC) is one of the most fatal human malignancies, with an
overall five-year survival rate of less than five percent. The high mortality rate associated w/ith PDAC is
primarily due to the late stage at which disease is diagnosed and the resistance of pancreatic cancer to
traditional chemotherapy and radiotherapy treatment approaches. These observations highlight the critical
need for early detection of pancreatic neoplasia at a stage where surgical resection can be curative. The
major goal of this proposal will be to use state-of-the-art mass spectrometry and genetically engineered
mouse models representing preinvasive or early, organ-confined stages of pancreatic neoplasia to identify a
comprehensive set of biomarkers that can be used in combination to prospectively diagnose early neoplasic
disease in humans. In Aim 1, we will identify serum biomarkers in genetically inbred mice that express an
activated allele of Kras (KrasG12D) in the pancreatic ductal epithelium and in mice with KrasG12D
expressed on a p16lnk4a- or p53-deficient background. Constitutive activation of KRAS is observed in over
90% of PDAC cases and it likely represents one of the earliest genetic lesions in pancreatic cancer. Aim 2
will utilize newly-derived pancreatic ductal cell lines from the same animal models described in Aim 1 to
characterize the complete spectrum of changes that occur in the cell-surface proteome and in the secretome
as neoplasia progresses from preinvasive lesions to fully metastatic disease. In Aim 3, we will utilize
histology-guided MALDI-TOF MS tissue profiling to identify biomarkers associated with early-stage
pancreatic neoplasia using pancreatic tissue from the animal models. From these results, we expect to
compile a comprehensive set of biomarkers for detection of early-stage pancreatic cancer. Finally, in Aim 4,
we will test the specificity and sensitivity of the early-stage biomarkers identified in the murine system for
their ability to diagnose pancreatic neoplasia using human serum samples collected from healthy donors and
cases representing chronic pancreatitis and PDAC. The goal of these studies will be the development of an
antibody-based diagnostic assay that can be used to screen high-risk patients for pancreatic cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining the role of Wnt11 and Wnt5a in regulating hematopoietic and skeletal stem cell self-renewal potential during homeostasis and stress
-
批准号:10731650
-
项目类别:
-
资助金额:$29.7万
-
财政年份:2023
-
负责人:CHRISTOPHER KLUG
-
依托单位:
Defining pathways promoting HSC self-renewal by mesenchymal stem/stromal cells
-
批准号:9126155
-
项目类别:
-
资助金额:$11.76万
-
财政年份:2015
-
负责人:CHRISTOPHER KLUG
-
依托单位:
Regulation of hematopoietic stem cell self-renewal by NUP98-HOXA9
-
批准号:8269740
-
项目类别:
-
资助金额:$36.26万
-
财政年份:2010
-
负责人:CHRISTOPHER KLUG
-
依托单位:
Regulation of hematopoietic stem cell self-renewal by NUP98-HOXA9
-
批准号:8471160
-
项目类别:
-
资助金额:$34.52万
-
财政年份:2010
-
负责人:CHRISTOPHER KLUG
-
依托单位:
Role of NF-kB in hematopoietic stem cells and leukemia-initiating cell formation
-
批准号:8022931
-
项目类别:
-
资助金额:$29.49万
-
财政年份:2010
-
负责人:CHRISTOPHER KLUG
-
依托单位:
Regulation of hematopoietic stem cell self-renewal by NUP98-HOXA9
-
批准号:8006300
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2010
-
负责人:CHRISTOPHER KLUG
-
依托单位:
Role of NF-kB in hematopoietic stem cells and leukemia-initiating cell formation
-
批准号:8433499
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2010
-
负责人:CHRISTOPHER KLUG
-
依托单位:
Role of NF-kB in hematopoietic stem cells and leukemia-initiating cell formation
-
批准号:8607152
-
项目类别:
-
资助金额:$28.6万
-
财政年份:2010
-
负责人:CHRISTOPHER KLUG
-
依托单位:
Role of NF-kB in hematopoietic stem cells and leukemia-initiating cell formation
-
批准号:8213544
-
项目类别:
-
资助金额:$29.49万
-
财政年份:2010
-
负责人:CHRISTOPHER KLUG
-
依托单位:
Regulation of hematopoietic stem cell self-renewal by NUP98-HOXA9
-
批准号:8102969
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2010
-
负责人:CHRISTOPHER KLUG
-
依托单位:
Analysis of a murine model of the AML1-ETO translocation
-
批准号:7844516
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2009
-
负责人:CHRISTOPHER KLUG
-
依托单位:
Analysis of a murine model of the AML1-ETO translocation
-
批准号:6821415
-
项目类别:
-
资助金额:$29.73万
-
财政年份:2004
-
负责人:CHRISTOPHER KLUG
-
依托单位:
Genetic mechanisms regulating B-lymphocyte commitment
-
批准号:7189929
-
项目类别:
-
资助金额:$34.37万
-
财政年份:2004
-
负责人:CHRISTOPHER KLUG
-
依托单位:
Analysis of a murine model of the AML1-ETO translocation
-
批准号:7406619
-
项目类别:
-
资助金额:$28.18万
-
财政年份:2004
-
负责人:CHRISTOPHER KLUG
-
依托单位:
Analysis of a murine model of the AML1-ETO translocation
-
批准号:7224266
-
项目类别:
-
资助金额:$28.18万
-
财政年份:2004
-
负责人:CHRISTOPHER KLUG
-
依托单位:
Genetic mechanisms regulating B-lymphocyte commitment
-
批准号:6864815
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2004
-
负责人:CHRISTOPHER KLUG
-
依托单位:
Genetic mechanisms regulating B-lymphocyte commitment
-
批准号:6775023
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2004
-
负责人:CHRISTOPHER KLUG
-
依托单位:
Genetic mechanisms regulating B-lymphocyte commitment
-
批准号:7038216
-
项目类别:
-
资助金额:$35.4万
-
财政年份:2004
-
负责人:CHRISTOPHER KLUG
-
依托单位:
Genetic mechanisms regulating B-lymphocyte commitment
-
批准号:7382547
-
项目类别:
-
资助金额:$33.72万
-
财政年份:2004
-
负责人:CHRISTOPHER KLUG
-
依托单位:
Analysis of a murine model of the AML1-ETO translocation
-
批准号:6931099
-
项目类别:
-
资助金额:$29.73万
-
财政年份:2004
-
负责人:CHRISTOPHER KLUG
-
依托单位:
海外基金